Understanding a patient’s journey is a crucial, yet often overlooked, aspect of cancer care that can significantly influence survivorship outcomes. A dedicated team of researchers at the University of Missouri undertook a study to delve into women’s experiences with cancer care, aiming to enhance healthcare strategies. Their recent report in Current Oncology unveils key findings suggesting opportunities for improvement in cancer care.
The study included women aged 40 and older receiving treatment for cancer in the United States. The researchers contacted over 1,200 patients and invited them to participate in the study. Sixty-four women responded, and 57 of them completed a survey for participation.
Of those who responded to the survey, most had completed treatment, but 10% stopped treatment before receiving the full recommended course. While 80% of the respondents remained with the same oncologist through every appointment, 8% changed physicians during the course of receiving treatment. Despite the low rate of changing oncologists, the study found that over 60% of respondents did not continue seeing the same primary care doctor throughout their treatment.
The survey uncovered some notable challenges faced by participants in the trial. These challenges included an inability to return to work, difficulty affording medication, and paying medical bills.
While the study's sample size may limit the researchers' ability to draw definitive conclusions, the results highlight both the strengths and the areas for improvement in cancer care. The fact that patients consistently maintained contact with their oncologist, a crucial factor in completing treatment, is a positive finding. However, the inconsistency in primary care visits presents a clear opportunity for the healthcare field. Addressing this challenge could pave the way for the best possible healthcare for cancer patients. The authors propose that a focus on coordination between specialists and primary care providers could significantly enhance cancer care and survivorship.
Sources: Current Oncol
